Skip to main content
. 2017 Dec 14;6:e27215. doi: 10.7554/eLife.27215

Figure 7. Calcium-mediated shaping of the CD4 TN-cell pTreg-cell differentiation potential in vivo.

Purified CD4 T cells from CD45.1/.2+ C57BL/6 Foxp3-GFP OT-II mice were cultured in IL-7 (10 ng/ml) with or without TG (4 nM). After 5 days live CD4 TN (CD44lo CD25lo CD8β- CD11b- CD11c- NK1.1- TCRγδ- Foxp3-GFP-) cells were flow-cytometry sorted and injected intravenously (0.5−1 × 106 cells) into sex-matched CD45.1+ C57BL/6 Foxp3-GFP recipient mice fed with Ovalbumin (OVA; 1.5% w/v) in the drinking water. One week after transfer, peripheral and mesenteric LNs (pLNs and mLNs, respectively), Peyer’s Patches (PPs) and spleen were recovered separately and donor-derived CD4 T cells were analyzed. (A) Diagram illustrating the experimental model. (B) Absolute numbers of donor-derived OT-II CD4 T (CD45.1+ CD45.2+ CD4+ TCRβ+ Vβ5+) cells recovered from pLNs, mLNs, PPs and spleen of recipient mice are shown as means ± s.e.m. for three independent experiments with two or three mice per group. (C) Representative Foxp3/Vβ5 contour-plots and proportions of Foxp3-GFP+ cells for gated donor-derived OT-II CD4 T (CD45.1+ CD45.2+ CD4+ TCRβ+ Vβ5+) cells recovered from mLNs are shown. (D–E) Percentages (D) and absolute numbers (E) of Foxp3-GFP+ among donor-derived OT-II CD4 T (CD45.1+ CD45.2+ CD4+ TCRβ+ Vβ5+) cells recovered from pLNs, mLNs, PPs and spleen of recipient mice are shown as means ± s.e.m. for three independent experiments with two or three mice per group. (B, D, E) Significance of differences were assessed using a two-tailed unpaired Student’s t-test. Values of p<0.05 were considered as statistically significant (*p<0.05; ns, not significant). figure supplement legends.

Figure 7.

Figure 7—figure supplement 1. OT-II CD4 TN cells are Ly-6C+and can be Ca2+-converted and tested for their ability to convert into pTreg cells in vivo.

Figure 7—figure supplement 1.

(A) Ly-6C fluorescence histograms of gated CD4 TN (CD4+ CD8α- TCRβ+ CD44lo CD25lo Foxp3-GFP-) cells recovered from LNs of C57BL/6 Foxp3-GFP and C57BL/6 Foxp3-GFP OT-II mice are shown. (B, C) Purified CD4 T cells from CD45.1/.2+ C57BL/6 Foxp3-GFP OT-II mice were cultured in IL-7 (10 ng/ml) with or without TG (4 nM). After 5 days, live CD4 TN (CD44lo CD25lo CD8β- CD11b- CD11c- NK1.1- TCRγδ- Foxp3-GFP-) cells were flow-cytometry sorted, analyzed for their cell surface expression of Ly-6C (B) and injected intravenously (0.5−1 × 106 cells) into sex-matched CD45.2+ C57BL/6 Foxp3-GFP recipient mice fed with Ovalbumin (+OVA; 1.5% w/v) or not (-OVA) in the drinking water (C). One week after transfer, mesenteric LNs (mLNs) were recovered and donor-derived CD4 T cells were analyzed. (C) Gating strategy and representative CD44/Foxp3 dot-plots for gated donor-derived OT-II CD4 T (CD45.1+ CD45.2+ CD4+ TCRβ+ Vβ5+) cells recovered from mLNs are shown. Percentages of Foxp3-GFP+ cells are indicated.
Figure 7—figure supplement 2. Calcium-mediated shaping of the CD4 TN-cell phenotype increases the pTreg-cell differentiation potential of OT-II CD4 TN cells in vivo.

Figure 7—figure supplement 2.

Purified CD4 T cells from CD45. 2+ and CD45.1/.2+ C57BL/6 Foxp3-GFP OT-II mice were cultured in IL-7 (10 ng/ml) without or with TG (4 nM), respectively. After 5 days live CD4 TN (CD44lo CD25lo CD8β- CD11b- CD11c- NK1.1- TCRγδ- Foxp3-GFP-) cells were flow-cytometry sorted, mixed at a 1:1 ratio and injected intravenously (0.5−1 × 106 cells) into sex-matched CD45.1+ C57BL/6 Foxp3-GFP-recipient mice gavaged with Ovalbumin (OVA; 50 mg) 4 and 24 hr later. 10 days after transfer, peripheral and mesenteric LNs (pLNs and mLNs, respectively), Peyer’s Patches (PPs) and spleen were recovered separately and donor-derived CD4 T cells were analyzed. (A) Diagram illustrating the experimental model and Ly-6C surface expression of transferred cells. (B) Representative CD45.1/Foxp3 dot-plots for gated donor-derived OT-II CD4 T (CD45.2+ CD4+ TCRβ+) cells recovered from Spleen, pLNs, mLNs and PP of recipient mice are shown. Absolute numbers of donor-derived Foxp3-GFP+ OT-II CD4 T cells recovered from pLNs, mLNs, PPs and spleen of recipient mice are shown as means ± s.e.m. for a representative experiment with four mice per group. (C) Total (pool of Spleen, pLNs, mLNs and PPs cells) absolute numbers of Foxp3-GFP+ OT-II CD4 T cells recovered from recipient mice are shown as means ± s.e.m. (D) Percentages of CD45.1+ cells among donor-derived Foxp3-GFP+ OT-II CD4 T (CD45.2+ CD4+ TCRβ+) cells recovered from pLNs, mLNs, PPs and spleen of recipient mice are shown as means ± s.e.m. (B, C) Significance of differences were assessed using a two-tailed paired Student’s t-test. Values of p<0.05 were considered as statistically significant (**p<0.01; ***p<0.001; ns, not significant).